Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study


Creative Commons License

Mohty M., Terpos E., Mateos M., Cavo M., Lejniece S., BEKSAÇ M., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.18, sa.10, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 18 Sayı: 10
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1016/j.clml.2018.06.018
  • Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Bortezomib, Global, Observational study, Routine practice, Stem cell transplantation, STEM-CELL TRANSPLANTATION, PLUS DEXAMETHASONE, TREATMENT PATTERNS, UNITED-STATES, BORTEZOMIB, INDUCTION, GUIDELINES, THERAPIES, SURVIVAL, ONCOLOGY
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Multiple myeloma (MM) remains an incurable disease, with little information available on its management in real-world clinical practice. The results of the present prospective, noninterventional observational study revealed great diversity in the treatment regimens used to treat MM. Our results also provide data to inform health economic, pharmacoepidemiologic, and outcomes research, providing a framework for the design of protocols to improve the outcomes of patients with MM.